(Report ID: 84009) Many drug interactions and side effects can not be detected until the drugs have been used by millions of people, and for a long time. Large, long-term drug safety studies are ideal to discover these real-world drug outcomes. For the first time, eHealthMe enables health professionals and patients to conduct these studies for their drugs. Click here to check your drugs now, in a whole new way. As of Nov, 21, 2008, eHealthMe analyzes 10,180,639 drug interactions and side effects of 21,667 FDA-approved drugs from 1977 to the present. Results on Nov, 21, 2008: 3 relevant incidents
Note:
- The incidents can not include all actual occurrences
- Data of 2008 is not complete
DISCLAIMER: All adverse drug reaction material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk. Basic information:
| Report ID | Date of submission | Patient age | Patient gender |
| 84009 | Mar, 24, 2006 | 77 | Male |
List of drugs the patient takes:
| Drug |
Diltiazem Hcl |
Lescol |
Ambien |
Allopurinol |
| Name |
Alopecia |
Blood Alkaline Phosphatase Increased |
Chest Discomfort |
Chest Pain |
Creatine Phosphokinase Decreased |
Decreased Appetite |
Hypotension |
Pulmonary Embolism |
Rash |
Results from eHealthMe: 3 relevent incidents1) Comparison with the patient's adverse outcomes:
| Name | Count (% of total reports) |
Alopecia | 2 (66.67%) |
Blood Alkaline Phosphatase Increased | 3 (100.00%) |
Chest Discomfort | 2 (66.67%) |
Chest Pain | 3 (100.00%) |
Creatine Phosphokinase Decreased | 3 (100.00%) |
Decreased Appetite | 2 (66.67%) |
Hypotension | 3 (100.00%) |
Pulmonary Embolism | 3 (100.00%) |
Rash | 3 (100.00%) |
3) Top co-used drugs drugs reported for the past 12 months:
Death: 0
Cancer: 0
| Name | Count (% of total reports) |
1 | Creatine Phosphokinase Decreased | 3 (100.00%) |
2 | Pulmonary Embolism | 3 (100.00%) |
3 | Rash | 3 (100.00%) |
4 | Chest Pain | 3 (100.00%) |
5 | Hypotension | 3 (100.00%) |
6 | Blood Alkaline Phosphatase Increased | 3 (100.00%) |
7 | Chest Discomfort | 2 (66.67%) |
8 | Aspartate Aminotransferase Increased | 2 (66.67%) |
9 | Alopecia | 2 (66.67%) |
10 | Decreased Appetite | 2 (66.67%) |
Want to have a risk analysis report like this for your drugs? Click here. ADVERTISEMENT
----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- Recent drug risk analysis reports:
|
|
|
 |
|
How to use the report?
Bring a copy of this report to a doctor's appointment to ensure drug risks are fully discussed and understood, in the process of risk and benefit assessment.
|
 |
|
ADVERTISEMENT
|
|
